- Home
- AMPY vs ALEC Comparison
AMPY vs ALEC Comparison
Compare AMPY & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- ALEC
- Stock Information
- Founded
- AMPY 2011
- ALEC 2013
- Country
- AMPY United States
- ALEC United States
- Employees
- AMPY 229
- ALEC N/A
- Industry
- AMPY Oil & Gas Production
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMPY Energy
- ALEC Health Care
- Exchange
- AMPY Nasdaq
- ALEC Nasdaq
- Market Cap
- AMPY 140.8M
- ALEC 124.0M
- IPO Year
- AMPY 2011
- ALEC 2019
- Fundamental
- Price
- AMPY $3.40
- ALEC $1.40
- Analyst Decision
- AMPY Strong Buy
- ALEC Buy
- Analyst Count
- AMPY 2
- ALEC 7
- Target Price
- AMPY $10.25
- ALEC $4.70
- AVG Volume (30 Days)
- AMPY 1.4M
- ALEC 596.8K
- Earning Date
- AMPY 08-06-2025
- ALEC 08-06-2025
- Dividend Yield
- AMPY N/A
- ALEC N/A
- EPS Growth
- AMPY N/A
- ALEC N/A
- EPS
- AMPY 0.39
- ALEC N/A
- Revenue
- AMPY $290,431,100.00
- ALEC $88,339,000.00
- Revenue This Year
- AMPY $2.88
- ALEC N/A
- Revenue Next Year
- AMPY $50.86
- ALEC $319.82
- P/E Ratio
- AMPY $8.24
- ALEC N/A
- Revenue Growth
- AMPY N/A
- ALEC N/A
- 52 Week Low
- AMPY $2.27
- ALEC $0.87
- 52 Week High
- AMPY $8.15
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- AMPY 55.08
- ALEC 48.14
- Support Level
- AMPY $3.18
- ALEC $1.36
- Resistance Level
- AMPY $3.56
- ALEC $1.51
- Average True Range (ATR)
- AMPY 0.25
- ALEC 0.12
- MACD
- AMPY -0.02
- ALEC -0.02
- Stochastic Oscillator
- AMPY 40.28
- ALEC 13.43
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.